ClinicalTrials.Veeva

Menu

Power Lung Versus Acapella After Coronary Artery Bypass Graft Surgery

S

South Valley University

Status

Active, not recruiting

Conditions

Coronary Artery Bypass Graft Surgery

Treatments

Device: Power lung device
Other: routine Physical Therapy program
Device: Acapella device

Study type

Interventional

Funder types

Other

Identifiers

NCT05260944
P.T.REC/012/002682

Details and patient eligibility

About

The purpose of the study is to compare between the power lung versus acapella on airway clearance after coronary artery bypass graft surgery.

Full description

In this part of the study the materials and methods will be presented under the following headings: subjects, equipments, procedures of the study and statistical procedures

  1. Subjects. Ninty patients of both sexes will participate in this study with an age range of 40 to 50 years old. They will be chosen from outpatient clinic, Qena University Hospital.

    Patients will be randomely assigned into three groups:

    Group A: patients will receive a two supervised sessions using acapella device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration.

    Group B: patients will receive a two supervised session using power lung device three sets for 10 repetitions two times daily from first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, Percussion and vibration).

    Group C. Patients will receive only routine physical Therapy program.

  2. Equipment:

  3. For evaluation: Arterial blood gases including: - paO2, paCO2, PH and O2 saturation. Spirometry measurements: - as forced vital capacity (FVC) andbforced expiratory volume in the first second (FEV1).

The incidence of PPCs and the length of postoperative stay: - using the Melbourne Group Scale Dyspnea. According to the revised or modified Borg scale or rating of perceived exersion.

The Rand SF 36 health survey questionnaire. 2. For treatment The power lung device. Acapella device.

Enrollment

90 estimated patients

Sex

All

Ages

40 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • They will be from 40-50 years old.
  • They will be patients undergo elective CABG surgery.
  • Non productive cough postoperatively.
  • Cough pain intensity > 5 as rated on a visual analogue scale (VAS) on postoperative day 1.

Exclusion criteria

  • Patients with chronic chest diseases.
  • Patients with an intensive postoperative care (ICU) stay > 48 hrs.
  • Uncooperative patients.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

90 participants in 3 patient groups

Group A
Experimental group
Description:
Group A. Thirty patients will receive a two supervised session using Acapella three sets for 10 repetitions two times daily from first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, Percussion and vibration).
Treatment:
Device: Acapella device
Group B
Experimental group
Description:
Thirty patients will receive a two supervised sessions using power lung device three sets for 10 repetitions from the first day postoperative until 7 days(André L.et al., 2016), in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration).
Treatment:
Device: Power lung device
Group C
Active Comparator group
Description:
Thirty patients will receive only routine physical Therapy program.
Treatment:
Other: routine Physical Therapy program

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems